Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease

Annual Review of Medicine

Volumn 61, Issue , 2010, Pages 105-119

  Whitsett, Jeffrey A ^a   Wert, Susan E ^a   Weaver, Timothy E ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Alveolar proteinosis; Interstitial lung disease; Pulmonary alveolar microlithiasis; Pulmonary fibrosis; Respiratory distress syndrome

Indexed keywords

ABC TRANSPORTER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; SODIUM PHOSPHATE COTRANSPORTER 2B; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; SURFACTANT ASSOCIATED PROTEIN;

CLINICAL FEATURE; HOMEOSTASIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG FUNCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; ADULT; CHILD; EPITHELIUM CELL; INFANT; LUNG ALVEOLUS; LUNG ALVEOLUS MACROPHAGE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; CHILD; EPITHELIAL CELLS; HUMANS; INFANT; LUNG DISEASES; MACROPHAGES, ALVEOLAR; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEINS;

EID: 77951909085     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.60.041807.123500     Document Type: Review

References (64)

1. Perez-Gil J. 2008. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim. Biophys. Acta 1778:1676-1695
2. Whitsett JA, Weaver TE. 2002. Mechanisms of disease: hydrophobic surfactant proteins in lung function and disease. N. Engl. J. Med. 347:2141-2148
3. Kingma PS, Whitsett JA. 2006. In defense of the lung: surfactant protein A and surfactant protein D. Curr. Opin. Pharmacol. 6:277-283
4. Korfhagen TR, Bruno MD, Ross GF, et al. 1996. Altered surfactant function and structure in SP-A gene targeted mice. Proc. Natl. Acad. Sci. USA 93:9594-9599
5. Wright JR. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5:58-68
6. Korfhagen TR, Sheftelyevich V, Burhans MS, et al. 1998. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273:28,438-443
7. Ikegami M, Whitsett JA, Jobe A, et al. 2000. Surfactant metabolism in SP-D gene-targeted mice. Am. J. Physiol. 279:L468-76
8. Ikegami M, Na CL, Korfhagen TR, Whitsett JA. 2005. Surfactant protein D influences surfactant ultra-structure and uptake by alveolar type II cells. Am. J. Physiol. 288:L552-61
9. Nogee LM. 2004. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu. Rev. Physiol. 66:601-623
10. Trapnell BC, Whitsett JA, Nakata K. 2003. Pulmonary alveolar proteinosis. N. Engl. J. Med. 349:2527-2539
11. Wang Y, Kuan PJ, Xing C, et al. 2009. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am. J. Hum. Genet. 84:52-59
12. Tsakiri KD, Cronkhite JT, Kuan PJ, et al. 2007. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. USA 104:7552-7557
13. Armanios MY, Chen JJ, Cogan JD,etal. 2007. Telomerase mutationsin families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356:1317-1326
14. Martinez-Moczygemba M, Doan ML, Elidemir O, et al. 2008. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region 1. J. Exp. Med. 205:2711-2716
15. Suzuki T, Sakagami T,Rubin BK, et al. 2008. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J. Exp. Med. 205:2703-2710
16. Corut A, Senyigit A, Ugur SA, et al. 2006. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am. J. Hum. Genet. 79:650-656
17. Huqun IS, MiyazawaH,IshiiK,etal. 2007. Mutationsinthe SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am. J. Respir. Crit. Care Med. 175:263-268
18. Ishihara Y, HagiwaraK, ZenK, et al. 2009. A case of pulmonary alveolar microlithiasis with an intragenetic deletion in SLC34A2 detected by a genome-wide SNP study. Thorax 64:365-367
19. Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. 2000. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 55:143-146
20. Cole FS, Hamvas A, Rubinstein P, et al. 2000. Population-based estimates of surfactant protein B deficiency. Pediatrics 105:538-541
21. Nogee LM, Garnier G, Dietz HC, et al. 1994. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J. Clin. Invest. 93:1860-1863
22. Nogee LM, Wert SE, Proffit SA, et al. 2000. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am. J. Respir. Crit. Care Med. 161:973-981
23. Clark JC, Wert SE, Bachurski CJ, et al. 1995. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc. Natl. Acad. Sci. USA 92:7794-7798
24. Hamvas A, Nogee LM, Mallory GB, et al. 1997. Lung transplantation for treatment of infants with surfactant protein B deficiency. J. Pediatr. 130:231-239
25. Shulenin S, Nogee LM, Annilo T, et al. 2004. ABCA3 gene mutation in newborns with fatal surfactant deficiency. N. Engl. J. Med. 350:1296-1303
26. Bullard JE, Wert SE, Whitsett JA, et al. 2005. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 172:1026-1031
27. Doan ML, Guillerman RP, Dishop MK, et al. 2008. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 63:366-373
28. Stahlman MT, Besnard V, Wert SE, et al. 2007. Expression of ABCA3 in developing lung and other tissues. J. Histochem. Cytochem. 55:71-83
29. Mulugeta S, Gray JM, Notarfrancesco KL, et al. 2002. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J. Biol. Chem. 277:22147-22155
30. Garmany TH, Moxley MA, White FV, et al. 2006. Surfactant composition and function in patients with ABCA3 mutations. Pediatr. Res. 59:801-805
31. Cheong N, Madesh M, Gonzales LW, et al. 2006. Functional and trafficking defects in ABCA3 mutants associated with respiratory distress syndrome. J. Biol. Chem. 281:9791-9800
32. Nogee LM, Dunbar AE, Wert SE, et al. 2001. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344:573-579
33. Thomas AQ, Lane K, Phillips J, 3rd, et al. 2002. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165:1322-1328
34. ChibbarR,ShihF,BagaM,etal. 2004. Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod. Pathol. 17:973-980
35. Vembar SS, Brodsky JL. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell. Biol. 9:944-957
36. Nakatsukasa K, Brodsky JL. 2008. The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic 9:861-870
37. Wang WJ, Mulugeta S, Russo SJ, Beers MF. 2003. Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative. J. Cell Sci. 116:683-692
38. Nerelius C, Martin E, Peng S, et al. 2008. Mutations linked to interstitial lung disease can abrogate antiamyloid function of prosurfactant protein C. Biochem. J. 416:201-209
39. Bridges JP, Wert SE, Nogee LM, Weaver TE. 2003. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J. Biol. Chem. 278:52739-52746
40. Glasser SW, Burhans MS, Korfhagen TR, et al. 2001. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc. Natl. Acad. Sci. USA 98:6366-6371
41. Mulugeta S, Maguire JA, Newitt JL, et al. 2007. Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4-and cytochrome c-related mechanisms. Am. J. Physiol. 293:L720-29
42. Bridges JP, Xu Y, Na CL, et al. 2006. Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J. Cell Biol. 172:395-407
43. Behr J, Thannickal VJ. 2009. Update in diffuse parenchymal lung disease 2008. Am. J. Respir. Crit. Care Med. 179:439-444
44. Korfei M, Ruppert C, Mahavadi P, et al. 2008. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178:838-846
45. Lawson WE, Crossno PF, Polosukhin VV, et al. 2008. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. 294:L1119-26
46. Ikegami M, Korfhagen TR, Whitsett JA, et al. 1998. Characteristics of surfactant from SP-A-deficient mice. Am. J. Physiol. 275:L247-54
47. Seymour JF, Presneill JJ. 2002. Pulmonary alveolar proteinosis: progress in the first 44 years. Am. J. Respir. Crit. Care Med. 166:215-235
48. Inoue Y, Trapnell BC, Tazawa R, et al. 2008. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am. J. Respir. Crit. Care Med. 177:752-762
49. Frazier AA, Franks TJ, Cooke EO, et al. 2008. From the archives of the AFIP: pulmonary alveolar proteinosis. Radiographics 28:883-899
50. Dranoff G, Crawford AD, Sadelain M, et al. 1994. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713-716
51. StanleyE, Lieschke GJ, Grail D, et al. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91:5592-5596
52. Robb L, Drinkwater CC, Metcalf D, et al. 1995. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc. Natl. Acad. Sci. USA 92:9565-9569
53. Reed JA, Ikegami M, Cianciolo ER, et al. 1999. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am. J. Physiol. 276:L556-63
54. Zsengeller ZK, Reed JA, Bachurski CJ,etal. 1998. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice. Hum. Gene Ther. 9:2101-2109
55. Uchida K, Beck DC, Yamamoto T, et al. 2007. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N. Engl. J. Med. 356:567-579
56. Shibata Y, Berclaz PY, Chroneos ZC, et al. 2001. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15:557-567
57. Ikegami M, Ueda T, Hull W, et al. 1996. Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am. J. Physiol. 14:L650-58
58. Dirkson U, Nishinakamura R, Groneck P, et al. 1997. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common β chain expression. J. Clin. Invest. 100:2211-2217
59. Cooke KR, Nishinakamura R, Martin TR, et al. 1997. Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 ß c receptor-deficient mice despite correction of alveolar proteinosis after BMT. Bone Marrow Transplant. 20:657-662
60. Chung MJ, Lee KS, Franquet T, et al. 2005. Metabolic lung disease: imaging and histopathologic findings. Eur. J. Radiol. 54:233-245
61. Mariotta S, Ricci A, Papale M, et al. 2004. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc. Diffuse Lung Dis. 21:173-181
62. Hashimoto M, Wang DY, Kamo T, et al. 2000. Isolation and localization of type IIb Na/Pi cotransporter in the developing rat lung. Am. J. Pathol. 157:21-27
63. Traebert M, Hattenhauer O, Murer H, et al. 1999. Expression of type II Na-P(i) cotransporter in alveolar type II cells. Am. J. Physiol. 277:L868-73
64. Cronkhite JT, Xing C, Raghu G, et al. 2008. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178:729-737